Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Inhibitex Starts Veronate Hospital Infection Phase III Trial In Infants

July 1, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Taste Technology Firm Senomyx Goes Public With $36M Offering

June 23, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...